Renal Cell Carcinoma

>

Latest News

Campbell Surveys Participants on Favorable-Risk Frontline Approach in RCC
Campbell Surveys Participants on Favorable-Risk Frontline Approach in RCC

November 14th 2024

During a Case-Based Roundtable® event, Matthew Campbell, MD, MS, moderated a discussion on treatment for a 61-year-old patient with lung-metastatic renal cell carcinoma.

ALLO-316 Shows 50% Response Rate in CD70-Positive RCC in Phase 1 Trial
ALLO-316 Shows 50% Response Rate in CD70-Positive RCC in Phase 1 Trial

November 11th 2024

Casdatifan Demonstrates Clinical Activity and Tolerability in Metastatic ccRCC
Casdatifan Demonstrates Clinical Activity and Tolerability in Metastatic ccRCC

November 5th 2024

RCC Abstracts Show Gaps in ASCO’s Language of Respect Guidelines
RCC Abstracts Show Gaps in ASCO’s Language of Respect Guidelines

October 31st 2024

Zakharia Evaluates Available Combination Options for Non–Clear Cell RCC
Zakharia Evaluates Available Combination Options for Non–Clear Cell RCC

October 19th 2024

Latest CME Events & Activities

Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board

View More

41st Annual CFS®: Innovative Cancer Therapy for Tomorrow

View More

Fighting Disparities and Saving Lives: An Exploration of Challenges and Solutions in Cancer Care

View More

Differentiating Adverse Events for Antibody-Drug Conjugates Across Solid Tumor Management

View More

<1
...
3738394041